Stirling Products (ASX: STI) has commenced two clinical trials following receipt of Ethics Approval. In Nigeria, Stirling’s clinical and marketing partner has commenced a trial in two groups of AIDS patients: one with HIV alone and the other for those who have Mycobacterium TB co-infection (HIV/TB). The recruitment of patients for the HIV alone arm [...]